Skip navigationEnd of navigation

Virtual Translational Research Conference

May 13, 2020

The Translational Advances in Cancer Prevention Agent Development Meeting will be held virtually on August 27 and 28, 2020.

Meeting Objectives:

The main goals of this meeting are to: 1) Foster the exchange of ideas and potentially new collaborative interactions among leading cancer prevention researchers from basic and clinical research, 2) Highlight new and emerging trends in immunoprevention and chemoprevention as well as new information from clinical trials, and 3) Highlight the significant resources available from the NCI to promote prevention agent development and rapid translation to clinical trials and to engage cancer researchers with novel prevention concepts.

Agenda Topics:

  • Advances in Small Molecule Agent Development
  • Advances in Immunomodulatory Agent Development
  • NCI PREVENT Preclinical Drug Development Program
  • Alternative Dosing and Combination Strategies to Reduce Toxicity
  • Emerging Vaccines for Cancer Prevention
  • Overview of the Cancer Prevention Clinical Trials Network (CP-CTNet)
  • Cancer Prevention Clinical Trials

More Information

DCP Meeting Information Page

‹ Back to News

Recent News

September 13, 2021

ODP Seeking Nominations for 2022 Early Stage Investigator Lecture

September 09, 2021

CASCADE Funding Opportunities

Learn more about CP-CTNet on the National Cancer Institute website

This project is supported by the National Cancer Institute (NCI) of the National Institutes of Health under award number U24CA242637. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.

Copyright © 2021, Frontier Science and Technology Research Foundation, Inc. All rights reserved.

Privacy and Terms of Use